Evidence map›Paper›PMID 27889954›Full record

ArticleThe Korean journal of internal medicine2018

Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib.

Sejeong Park, Soyoung Park, Hana Choi, Ji Young Park, Hyo Seok Lim, Myung Jae Park, Si-Young Kim

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Korean journal of internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Invasive Pulmonary Aspergillosis.Journal of fungi (Basel, Switzerland) · 2023
    Review
  6. Idiopathic pulmonary fibrosis with chronic necrotizing pulmonary aspergillosis: a case report.International journal of clinical and experimental pathology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sejeong ParkDepartment of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Soyoung ParkDepartment of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Hana ChoiDepartment of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Ji Young ParkDepartment of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Hyo Seok LimDepartment of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Myung Jae ParkDepartment of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Si-Young KimDepartment of Hematology-Oncology, Kyung Hee University Medical Center, Seoul, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungErbB ReceptorsFatal OutcomeGefitinibHumansInvasive Pulmonary AspergillosisLung NeoplasmsMaleMiddle AgedProspective StudiesAntineoplastic AgentsErbB ReceptorsGefitinibCarcinoma, non-small-cell lungGefitinibInvasive pulmonary aspergillosis

Identifiers

PMID27889954
PMCPMC5768534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.